ZELSUVMI is the FIRST and ONLY FDA-approved at-home, prescription treatment for molluscum contagiosum in adults and children 1 year of age and older. What is molluscum? How can …

Zelsuvmi gel (berdazimer 10.3%) is a prescription medicine used to treat the viral skin condition, molluscum contagiosum (MC) in adults and children aged 1 year and older. Zelsuvmi gel is …

ZELSUVMI is a nitric oxide (NO) releasing agent indicated for the topical treatment of molluscum contagiosum (MC) in adults and pediatric patients 1 year of age and older. (1) Dispense equal...

ZELSUVMI is the only FDA-approved topical gel for molluscum that’s applied at home. Discover how it works and what makes it different from other treatments.

ZELSUVMI (berdazimer) topical gel, 10.3% is a nitric oxide (NO) releasing agent indicated for the topical treatment of molluscum contagiosum in adults and pediatric patients one year of age …

Zelsuvmi is the first FDA-approved at-home treatment for molluscum contagiosum, now available for patients aged ≥1 via retail and mail-order pharmacies.

ZELSUVMI (berdazimer) topical gel is an opaque white to off-white gel containing 10.3% berdazimer (equivalent to 10.9% berdazimer sodium). ZELSUVMI is supplied as two gel …

Berdazimer (Zelsuvmi) is a topical, nitric oxide–releasing agent that is theorized to treat molluscum contagiosum through antiviral and immunomodulatory properties. 1 It is labeled for …

Learn how ZELSUVMI, the first and only FDA-approved at-home gel for molluscum, works and what to expect with at-home use.

Zelsuvmi BERDAZIMER treats molluscum, a common viral skin infection that causes small, firm bumps on the skin. It will not treat infections caused by bacteria. Compare nitric oxide …